Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.
about
The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitisGenistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model.Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease.Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats.The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury.
P2860
Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Peroxisome proliferator activa ...... erimental fatty liver disease.
@ast
Peroxisome proliferator activa ...... erimental fatty liver disease.
@en
type
label
Peroxisome proliferator activa ...... erimental fatty liver disease.
@ast
Peroxisome proliferator activa ...... erimental fatty liver disease.
@en
prefLabel
Peroxisome proliferator activa ...... erimental fatty liver disease.
@ast
Peroxisome proliferator activa ...... erimental fatty liver disease.
@en
P2093
P2860
P1476
Peroxisome proliferator activa ...... erimental fatty liver disease.
@en
P2093
Bao-Li Liang
Cai-Yan Zhao
Jian-Mei Li
Ling-Ling Jiang
Zhuo-Jun Deng
P2860
P304
P407
P577
2004-05-01T00:00:00Z